Elucidating the Antiviral Mechanism of Different MARCH Factors
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
This study examines the mechanism utilized by different MARCH proteins to restrict retrovirus infection. MARCH proteins block the incorporation of envelope glycoproteins to the budding virions.
Article activity feed
-
-
SciScore for 10.1101/2020.12.22.422953: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Blots were probed using the following antibodies: goat anti-MLV gp70 (66), goat anti-MMTV polyclonal (67), rat anti-MLV transmembrane protein/p15E (clone 42/114, Kerafast) anti-MLVsuggested: (Creative Diagnostics Cat# DCABH-2412, RRID:AB_2476319)anti-MMTVsuggested: (Rockland Cat# 100-401-P12S, RRID:AB_2610798)anti-MLV transmembrane protein/p15Esuggested: NoneLysates were then resolved on 10% sodium dodecyl sulfate polyacrylamide gels and blots were probed … SciScore for 10.1101/2020.12.22.422953: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Antibodies Sentences Resources Blots were probed using the following antibodies: goat anti-MLV gp70 (66), goat anti-MMTV polyclonal (67), rat anti-MLV transmembrane protein/p15E (clone 42/114, Kerafast) anti-MLVsuggested: (Creative Diagnostics Cat# DCABH-2412, RRID:AB_2476319)anti-MMTVsuggested: (Rockland Cat# 100-401-P12S, RRID:AB_2610798)anti-MLV transmembrane protein/p15Esuggested: NoneLysates were then resolved on 10% sodium dodecyl sulfate polyacrylamide gels and blots were probed using the following antibodies: rabbit anti-FLAG (Cell Signaling Technology), rabbit anti-V5 (Invitrogen), mouse anti-Flavivirus envelope 4G2 (BEI Resources, NIH, NIAID NR-50327), rabbit anti-AU1 (Novus Biologicals) anti-V5suggested: Noneanti-AU1suggested: NoneCells were harvested and 1 × 105 cells were stained with 1:50 of rabbit anti-MARCH1 (Thermo Fisher Scientific Cat#PA5-69223) or 1:50 of rabbit IgG isotype antibody (Thermo Fisher Scientific Cat#02-6102) for 30 minutes at 4°C. rabbit IgGsuggested: (Thermo Fisher Scientific Cat# 02-6102, RRID:AB_2532938)Blots were probed with the following antibodies: rabbit anti-MARCH1 (Invitrogen Cat#PA5-69223), rabbit anti-MARCH8 (Invitrogen Cat#30220) anti-MARCH8suggested: NoneBriefly, 50 μl proteinA Dynabeads (Thermo Fisher Scientific) were pre-incubated with 1:50 dilution of rabbit anti-MARCH1 (Invitrogen Cat#PA5-69223) or 1:25 dilution of rabbit anti-MARCH8 (Proteintech Cat#14119-1-AP) antibodies. anti-MARCH1suggested: (Thermo Fisher Scientific Cat# PA5-69223, RRID:AB_2689421)Cell lysates were incubated with antibodies-coated protein A dynabeads overnight at 4°C, washed, and eluted. antibodies-coated proteinsuggested: NoneProtein A Dynabeads were pre-incubated with anti-Myc (Cell Signaling Technology), or 1:20 of culture supernatant of 372 (ATCC CRL-1893) and then cell lysates were added to antibodies-bound protein A dynabeads and incubated at room temperature for 1 hour, washed, and eluted, followed by SDS-PAGE and western blot analysis detecting for MLV p15E or MARCH(myc). Protein A Dynabeads were pre-incubated with anti-Myc (Cell Signaling Technology)suggested: NoneExperimental Models: Cell Lines Sentences Resources EL4 cells (ATCC) were cultured in RPMI media with 10% FBS, P/S, and 0.05 mM β-mercaptoethanol (β-ME; Bio-Rad). EL4suggested: NoneIn the case of human MARCH genes, hM1 cDNA was synthesized from HeLa cell RNA. HeLasuggested: CLS Cat# 300194/p772_HeLa, RRID:CVCL_0030)For the MMTV transfection experiments, we seeded 293T cells in a 6-well plate (0.5 × 106/well) and transfected them with 5 μg of MMTV hybrid provirus (HP) plasmid (34), 50ng of rat glycocorticoid receptor (RSVGR) construct and 1 μg mM1, 2, 3, 8 or E. 293Tsuggested: NoneInterferon treatment of cells: 0.5 × 104 cells of MutuDC1940, EL-4, NIH3T3, BMDMs and BMDCs were seeded in a 96-well plate for 24 hours. EL-4suggested: NoneVirus preparation: MLV stocks were prepared by transfecting 293FT cells (Invitrogen) seeded in 10-cm-diameter cell culture dishes using Lipofectamine3000 (Thermo Fisher Scientific) with 25 μg of an MLV infectious clone (pLRB302) per manufacturer’s recommendation. 293FTsuggested: ATCC Cat# PTA-5077, RRID:CVCL_6911)Infection assays: To examine the effect of MLV infection on MARCH gene expression, 0.5 × 104 cells of MutuDC1940, EL4, NIH3T3 were seeded in 96-well plate followed by infection with MLV (5 MOI) via spinoculation as previously described (68). NIH3T3suggested: NoneExperimental Models: Organisms/Strains Sentences Resources BMDCs and BMDMs were generated from 6-9 week C57BL6/N mice as previously described (55). C57BL6/Nsuggested: NoneWe introduced in the NL4-3XhoI-EcoRI fragment two stop codons at residues 705 and 707 (R705Stop and R707Stop) of the envelope ORF located at the N’ terminus of the cytosolic tail, using the Phusion Site-Directed Mutagenesis Kit (Thermo Fisher Scientific). R705Stopsuggested: NoneSoftware and Algorithms Sentences Resources Stained populations from our FACS experiments were further analyzed using Flowjo software version 10.7.1. Flowjosuggested: (FlowJo, RRID:SCR_008520)Statistical analysis: Statistical analyses were performed using GraphPad Prism software version 8.2. GraphPad Prismsuggested: (GraphPad Prism, RRID:SCR_002798)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-